Corbus Pharmaceuticals listed on the stock exchange and received rating reports from various firms.
2 reports, 1 independent
Updated Sep 17
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Corbus Pharmaceuticals listed on the stock exchange and received rating reports from various firms.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Corbus Pharmaceuticals
company in Norwood, United States
-
Nasdaq
American fully electronic stock exchange
Related events
- MarketBeat is reporting on consensus ratings for Aehr Test Systems, a company whose stock trades on the Nasdaq exchange.
- FirstCash traded on the Nasdaq stock exchange, filed required reports with the SEC, and saw its stock price affected by analyst ratings.
- Unicycive Therapeutics, Inc. is facing investigator findings regarding manufacturing compliance issues from the FDA.
- Market summary on August 5, 2026, noting strong earnings reports from companies and analyzing Nasdaq's performance and trends.
- Earnings reports from major tech companies like Alphabet and ServiceNow led to stock drops and reduced forecasts.